Article
A unique human mutant B-lymphoblastoid cell line (ataxia telangiectasia) which exhibits increased sister-chromatid exchange retaining hypersensitivity to neocarzinostatin and bleomycin.
Mutation research - 1 Jun 1990
Li M J, Shiraishi Y
Abstract excerpt
Chromosome aberrations and sister-chromatid exchanges (SCEs) were examined in 4 ataxia telangiectasia (AT)-derived B-lymphoblastoid cell lines (B-LCLs) (AT-S, AT-SHI, AT-SHI B13A and AsHa) following treatments with neocarzinostatin (NCS) and bleomycin. All of these cell lines exhibited extremely high frequencies of chromosome aberrations with the NCS and bleomycin treatments. Among them, AsHa, a mutant B-LCL...
Topics
- Antibiotics, Antineoplastic
- Ataxia Telangiectasia
- B-Lymphocytes
- Bleomycin
- Bloom Syndrome
- Bromodeoxyuridine
- Cell Division
- Cell Line
- Chromosome Aberrations
- Dose-Response Relationship, Drug